https://pmc.ncbi.nlm.nih.gov/articles/PMC24568/
Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of...
In an attempt to improve behavioral memory, we devised a strategy to amplify the signal-to-noise ratio of the cAMP pathway, which plays a central role in...
a typephosphodiesterase inhibitorthe establishmentrolipramiv
https://pmc.ncbi.nlm.nih.gov/articles/PMC2646200/
Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity...
Cyclic nucleotide phosphodiesterase-8 (PDE8) is a family of cAMP-specific enzymes and plays important roles in many biological processes, including T-cell...
structural studies
https://pmc.ncbi.nlm.nih.gov/articles/PMC2483323/
Pomegranate Juice: Is It the New, All-Natural Phosphodiesterase Type 5 Inhibitor? - PMC
https://www.cochrane.org/evidence/CD002230_phosphodiesterase-iii-inhibitor-class-drugs-taken-orally-and-long-term-are-associated-increased
Phosphodiesterase III inhibitor class drugs taken orally and long term are associated with...
https://www.biospace.com/phosphodiesterase-4-inhibitor-curbs-inflammation-in-copd
Phosphodiesterase-4 Inhibitor Curbs Inflammation In COPD - BioSpace
phosphodiesterase 4 inhibitorcurbsinflammationcopd
https://pmc.ncbi.nlm.nih.gov/articles/PMC10449067/
Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive...
Ensifentrine is a novel, selective, dual phosphodiesterase (PDE)3 and PDE4 inhibitor with bronchodilator and antiinflammatory effects. Replicate phase III...
https://pmc.ncbi.nlm.nih.gov/articles/PMC10932209/
The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and...
Atherosclerotic cardiovascular disease (ASCVD) stands as the leading global cause of mortality. Addressing this vital and pervasive condition requires a...
phosphodiesterase 3 inhibitorthe role